AT1 0.00% 2.7¢ atomo diagnostics limited

Media Update, page-618

  1. 519 Posts.
    lightbulb Created with Sketch. 93
    Atomo Diagnostics Limited (ASX: AT1) (Atomo) is pleased to announce that the Therapeutic Goods Administration (TGA) has approved its rapid SARS-CoV-2 antigen blood test for use by medical professionals in Australia.

    Australian Therapeutic Goods Administration (TGA) has approved the AtomoRapid™ COVID-19 (IgG/IgM) test for inclusion on the ARTG for supply to departments of health, laboratories, medical practitioners and health care professionals in residential and aged care facilities

    The only test we can buy from Atomo is the self-test for HIV
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.000(0.00%)
Mkt cap ! $17.25M
Open High Low Value Volume
2.8¢ 2.9¢ 2.7¢ $10.03K 365.9K

Buyers (Bids)

No. Vol. Price($)
7 668702 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 11840 2
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.